BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 25894803)

  • 21. Combating the dual burden: therapeutic targeting of common pathways in obesity and type 2 diabetes.
    Scheen AJ; Van Gaal LF
    Lancet Diabetes Endocrinol; 2014 Nov; 2(11):911-22. PubMed ID: 24731666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adherence to weight loss medications; post-marketing study from HMO pharmacy data of one million individuals.
    Hemo B; Endevelt R; Porath A; Stampfer MJ; Shai I
    Diabetes Res Clin Pract; 2011 Nov; 94(2):269-75. PubMed ID: 21907442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacotherapy considerations in diabetes and obesity: setting patients up for success.
    Cornell S; D'Souza J
    Postgrad Med; 2014 Mar; 126(2):100-9. PubMed ID: 24685973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obesity: new perspectives and pharmacotherapies.
    Palamara KL; Mogul HR; Peterson SJ; Frishman WH
    Cardiol Rev; 2006; 14(5):238-58. PubMed ID: 16924165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Weight management in type 2 diabetes mellitus.
    Siram AT; Yanagisawa R; Skamagas M
    Mt Sinai J Med; 2010; 77(5):533-48. PubMed ID: 20960555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medical management of obesity.
    Giri M
    Acta Clin Belg; 2006; 61(5):286-94. PubMed ID: 17240746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiometabolic Effects of Anti-obesity Pharmacotherapy.
    Crawford AR; Alamuddin N; Amaro A
    Curr Atheroscler Rep; 2018 Mar; 20(4):18. PubMed ID: 29511882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological Approaches in the Treatment and Maintenance of Weight Loss.
    Van Gaal L; Dirinck E
    Diabetes Care; 2016 Aug; 39 Suppl 2():S260-7. PubMed ID: 27440841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacotherapy for weight loss: the cardiovascular effects of the old and new agents.
    Walter CP; Bleske BE; Dorsch MP
    J Clin Pharm Ther; 2014 Oct; 39(5):475-84. PubMed ID: 24924286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Weight loss medications--where do they fit in?
    Dixon JB
    Aust Fam Physician; 2006 Aug; 35(8):576-9. PubMed ID: 16894428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Shedding light on weight loss: A narrative review of medications for treating obesity.
    Darapaneni H; Lakhanpal S; Chhayani H; Parikh K; Patel M; Gupta V; Anamika F; Munjal R; Jain R
    Rom J Intern Med; 2024 Mar; 62(1):3-11. PubMed ID: 37752761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metformin: an Old Therapy that Deserves a New Indication for the Treatment of Obesity.
    Igel LI; Sinha A; Saunders KH; Apovian CM; Vojta D; Aronne LJ
    Curr Atheroscler Rep; 2016 Apr; 18(4):16. PubMed ID: 26888066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel therapies for cardiometabolic risk reduction and implications for clinical practice.
    Watson KE
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S37-42. PubMed ID: 17934393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting thermogenesis and related pathways in anti-obesity drug discovery.
    Clapham JC; Arch JR
    Pharmacol Ther; 2011 Sep; 131(3):295-308. PubMed ID: 21514319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Weight management for type 2 diabetes mellitus: global cardiovascular risk reduction.
    Lee M; Aronne LJ
    Am J Cardiol; 2007 Feb; 99(4A):68B-79B. PubMed ID: 17307059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update on obesity pharmacotherapy.
    Bray GA; Ryan DH
    Ann N Y Acad Sci; 2014 Apr; 1311():1-13. PubMed ID: 24641701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Addressing the unmet medical need for safe and effective weight loss therapies.
    Arbeeny CM
    Obes Res; 2004 Aug; 12(8):1191-6. PubMed ID: 15340099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New medications for treatment of obesity: metabolic and cardiovascular effects.
    Pucci A; Finer N
    Can J Cardiol; 2015 Feb; 31(2):142-52. PubMed ID: 25661549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medication-Assisted Weight Loss in the Age of Obesity.
    Leahy LG
    J Psychosoc Nurs Ment Health Serv; 2017 Aug; 55(8):21-26. PubMed ID: 28771283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An up-to-date evaluation of lorcaserin hydrochloride for the treatment of obesity.
    Tchang BG; Abel B; Zecca C; Saunders KH; Shukla AP
    Expert Opin Pharmacother; 2020 Jan; 21(1):21-28. PubMed ID: 31693425
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.